| Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease SC Clifford, ME Cockman, AC Smallwood, DR Mole, ER Woodward, ... Human molecular genetics 10 (10), 1029-1038, 2001 | 457 | 2001 |
| Germline SDHB mutations and familial renal cell carcinoma C Ricketts, ER Woodward, P Killick, MR Morris, D Astuti, F Latif, ER Maher Journal of the National Cancer Institute 100 (17), 1260-1262, 2008 | 410 | 2008 |
| Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD CJ Ricketts, JR Forman, E Rattenberry, N Bradshaw, F Lalloo, L Izatt, ... Human mutation 31 (1), 41-51, 2010 | 408 | 2010 |
| Whole-genome sequencing of patients with rare diseases in a national health system SJ Turro E, Astle WJ, Megy K, Gräf S, Greene D, Shamardina O, Allen HL ... Nature, 2020 | 392 | 2020 |
| Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations A Moran, C O’hara, S Khan, L Shack, E Woodward, ER Maher, F Lalloo, ... Familial cancer 11, 235-242, 2012 | 355 | 2012 |
| Germline SDHD mutation in familial phaeochromocytoma D Astuti, F Douglas, TWJ Lennard, IA Aligianis, ER Woodward, ... The Lancet 357 (9263), 1181-1182, 2001 | 302 | 2001 |
| Genotype-phenotype correlations in von Hippel-Lindau disease MER Ong KR, Woodward ER, Killick P, Lim C, Macdonald F Human mutation 28 (2), 143-9, 2007 | 280 | 2007 |
| Penetrance estimates for BRCA1 and BRCA2based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should … DG Evans, A Shenton, E Woodward, F Lalloo, A Howell, ER Maher BMC cancer 8, 1-9, 2008 | 263 | 2008 |
| Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes ERNG Thierry Frebourg, Svetlana Bajalica Lagercrantz, Carla Oliveira, Rita ... European Journal Human Genetics, 2020 | 215 | 2020 |
| Tumour risks and genotype–phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD KA Andrews, DB Ascher, DEV Pires, DR Barnes, L Vialard, RT Casey, ... Journal of medical genetics 55 (6), 384-394, 2018 | 215 | 2018 |
| Germline FH Mutations Presenting With Pheochromocytoma GR Clark, M Sciacovelli, E Gaude, DM Walsh, G Kirby, MA Simpson, ... The Journal of Clinical Endocrinology & Metabolism 99 (10), E2046-E2050, 2014 | 180 | 2014 |
| Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high‐risk and population risk women is ineffective ER Woodward, HV Sleightholme, AM Considine, S Williamson, ... BJOG: An International Journal of Obstetrics & Gynaecology 114 (12), 1500-1509, 2007 | 159 | 2007 |
| Genetic Predisposition to Phaeochromocytoma: Analysis of Candidate Genes GDNF, RET and VHL ER Woodward, C Eng, R McMahon, R Voutilainen, NA Affara, BAJ Ponder, ... Human Molecular Genetics 6 (7), 1051-1056, 1997 | 154 | 1997 |
| Association of mismatch repair mutation with age at cancer onset in Lynch syndrome: implications for stratified surveillance strategies NAJ Ryan, J Morris, K Green, F Lalloo, ER Woodward, J Hill, EJ Crosbie, ... JAMA oncology 3 (12), 1702-1706, 2017 | 149 | 2017 |
| Risk of breast cancer in male BRCA2 carriers DGR Evans, I Susnerwala, J Dawson, E Woodward, ER Maher, F Lalloo Journal of medical genetics 47 (10), 710-711, 2010 | 146 | 2010 |
| Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening A Smith, A Moran, MC Boyd, M Bulman, A Shenton, L Smith, R Iddenden, ... Journal of medical genetics 44 (1), 10-15, 2007 | 130 | 2007 |
| Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers AC Antoniou, A Shenton, ER Maher, E Watson, E Woodward, F Lalloo, ... Breast Cancer Research 8, 1-6, 2006 | 122 | 2006 |
| Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification MT Parsons, E Tudini, H Li, E Hahnen, B Wappenschmidt, L Feliubadaló, ... Human mutation 40 (9), 1557-1578, 2019 | 121 | 2019 |
| A comprehensive next generation sequencing–based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma E Rattenberry, L Vialard, A Yeung, H Bair, K McKay, M Jafri, N Canham, ... The Journal of Clinical Endocrinology & Metabolism 98 (7), E1248-E1256, 2013 | 109 | 2013 |
| Von Hippel-Lindau disease and endocrine tumour susceptibility ER Woodward, ER Maher Endocrine-related cancer 13 (2), 415-425, 2006 | 107 | 2006 |
Evans DG*, Evans G*University of ManchesterE-mail confirmado em mft.nhs.uk
